已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Combined thrombolytic therapy with low-dose recombinant tissue plasminogen activator and urokinase for patients with acute cerebral infarction

医学 溶栓 尿激酶 重组组织纤溶酶原激活剂 脑梗塞 内科学 纤溶酶原激活剂 组织纤溶酶原激活剂 梗塞 外科 麻醉 心肌梗塞 缺血性中风 缺血 改良兰金量表
作者
Guangmin Zhu
出处
期刊:Chinese Journal of Cerebrovascular Diseases
摘要

Objective To observe the efficacy and safety of combined thrombolytic therapy with recombinant tissue plasminogen activator(rt-PA) and urokinase(UK) on patients with acute cerebral infarction.Method Eighty-one patients with acute cerebral infarction(6 hours from onset) were recruited and randomly allocated into four groups:combined thrombolysis group(n=20),rt-PA group(n=22),UK group(n=18),and control group(n=21).The patients in combined thrombolysis group received rt-PA 20 mg and UK 300 000-500 000 IU;the patients in rt-PA group received rt-PA 0.9 mg/kg intravenously;the patients in UK group received UK 10 000-20 000 IU/kg(patients with body weight 75 kg received the same dose of medication as 75 kg),and the maximum dose of UK was 1 500 000 IU;the patients in the control group received to no thrombolytic drugs.The outcome score were evaluated according to the National Institute of Health Stroke Scale(NIHSS) before treatment and four weeks after symptom onset,and to evaluate hemorrhagic transformation,recurrent infarction,and death as the safety indicators.Results ①Before treatment the NIHSS scores in the combined thrombolysis,rt-PA,UK,and control groups were 18.1±3.6,17.9±3.6,18.0±3.4,and 17.3±4.0,respectively,and after treatment they were 9.1±5.6,8.8±5.5,9.6±5.2,and 14.1±4.6,respectively.There were significant differences in each group before and after treatment(P0.01),and also between the 3 thrombolysis groups and the control group(P0.01);but there were no significant differences between each other of the 3 thrombolysis groups.②The total effective rates in the 4 groups but were 85.0%(17/20),86.4%(19/22),83.3%(15/18),and 42.9%(9/21),respectively.As compared between the 3 thrombolysis groups with the control group,there were significant differences(P0.05);and there were no significant differences among the 3 thrombolysis groups(P0.05).③One patient had new attack of cerebral infarction,and 1 patient had hemorrhagic transformation within 24 hours after thrombolytic therapy in the combined thrombolytic group;3 patients had hemorrhagic transformation in the rt-PA group;1 patient had new attack of cerebral infarction in the UK group;2 patients had hemorrhagic transformation,and 1 of them died.One patient had new attack of cerebral infarction,and 1 patient was died in the control group.Conclusion The combined thrombolytic therapy with low-dose rt-PA and UK for the treatment of acute cerebral infarction is safe and effective.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
如梦完成签到 ,获得积分10
1秒前
funny完成签到 ,获得积分10
1秒前
charint完成签到,获得积分10
2秒前
我去吃饭完成签到 ,获得积分10
3秒前
默mo完成签到 ,获得积分10
3秒前
5秒前
charint发布了新的文献求助10
5秒前
jedeecn完成签到,获得积分20
7秒前
曾经的帅哥完成签到,获得积分10
7秒前
Anna完成签到 ,获得积分10
7秒前
汉堡包的应助被richardhipower采纳,获得10
7秒前
日出前完成签到 ,获得积分10
8秒前
谦让夏山完成签到 ,获得积分10
8秒前
酸菜爱生活完成签到 ,获得积分10
8秒前
11秒前
千诺完成签到 ,获得积分10
11秒前
淡然雁梅完成签到 ,获得积分10
11秒前
倪妮完成签到 ,获得积分10
12秒前
科研通AI6.2的应助被iceicefdtd采纳,获得10
12秒前
bluemoon发布了新的文献求助10
12秒前
Lee完成签到 ,获得积分10
13秒前
大模型的应助被221008zn采纳,获得10
13秒前
jiuzhege完成签到 ,获得积分10
14秒前
我想进步完成签到,获得积分10
15秒前
baolong完成签到,获得积分10
15秒前
16秒前
harry完成签到,获得积分10
17秒前
17秒前
17秒前
烟花的应助被小豆包采纳,获得10
17秒前
冷静新烟完成签到,获得积分10
17秒前
解惑大师完成签到 ,获得积分10
18秒前
深情安青的应助被richardhipower采纳,获得10
18秒前
鲁大海完成签到,获得积分10
19秒前
知性的夏之完成签到 ,获得积分10
19秒前
墨白完成签到,获得积分10
20秒前
欢喜的文轩完成签到 ,获得积分10
20秒前
初椿完成签到 ,获得积分10
21秒前
典雅的皓轩完成签到 ,获得积分10
22秒前
子皿完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189866
求助须知:如何正确求助?哪些是违规求助? 9577019
关于积分的说明 21851254
捐赠科研通 7787798
什么是DOI,文献DOI怎么找? 3435795
关于科研通互助平台的介绍 2559856
邀请新用户注册赠送积分活动 2482699